Science · 43 views
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging
Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging.
AI Summary
Research has identified a potential link between the active ingredient in certain weight-loss medications and biological aging. The study, which focused on adults with HIV, found that semaglutide slowed markers of biological aging. This is the first clinical evidence suggesting that the medication may influence human aging. While the findings are promising, scientists emphasize the need for further research before drawing conclusions about the medication's effects on aging.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Science
Continue reading recent Science coverage
- Elections are more predictable than they lookContinue reading
- Inside the Pentagon, the pressure is on to find a home for a new spaceportContinue reading
- Tiny Genetic Tweak From An Ancient Virus Might've Prevented Chimpanzees From Developing Brains Like OursContinue reading
- Crows can evaluate visual info twice as fast as mammalsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow